Brimonidine L-Tartrate

CAS: 70359-46-5

Ref. TR-B677530

Produktinformation

• Name: Brimonidine L-Tartrate
• Synonyme: Brimonidine tartarate, Brimonidine D-tartrate, Brimonidine Tartrate, 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine (2R,3R)-2,3-dihydroxybutanedioate (1:1), 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine [R-(R*,R*)]-2,3-dihydroxybutanedioate (1:1), AGN 190342LF, Alphagan, Alphagan P, Brimonidine Purite, Brimonidine tartrate, Brominide tartrate, (5-Bromo-quinoxalin-6-yl)-(4,5-dihydro-1H-imidazol-2-yl)-amine L-tartrate, 5-Bromo-N-(4,5-Dihydro-1H-Imidazol-2-Yl)-6-Quinoxalinamine Tartrate, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine 2,3-dihydroxybutanedioate (1:1), 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine 2,3-dihydroxybutanedioate (salt), 6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1), 6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, [R-(R*,R*)]-2,3-dihydroxybutanedioate (1:1), Agn 190342Lf, Mirvaso

Beschreibung

Applications It is an α2 receptor agonist. It is a drug used to treat glaucoma.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Katz, L.J., et al.: Am. J. Ophthalmol., 127, 20 (1999), Cantor, L. B., Expert Opin. Pharmacother., 1, 815 (2000),

• Marke: TRC

Chemische Eigenschaften

• Molekulargewicht: 442.22
• Formel: C₁₁H₁₀BrN₅·C₄H₆O₆
• Farbe/Form: Neat
• InChl: InChI=1S/C11H10BrN5.C4H6O6/c12-9-7(17-11-15-5-6-16-11)1-2-8-10(9)14-4-3-13-8, 5-1(3(7)8)2(6)4(9)10/h1-4H,5-6H2,(H2,15,16,17), 1-,2-/m.1/s1, 1-2,5-6H,(H,7,8)(H,9,10)/t
• InChI Key: InChIKey=QZHBYNSSDLTCRG-LREBCSMRSA-N
• SMILES: Brc1c(NC2=NCCN2)ccc2nccnc12.O=C(O)[C@H](O)[C@@H](O)C(=O)O